A rupture of a lung metastatic lesion of colon cancer, leading to pneumothorax caused by bevacizumab

8Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

The patient was a 57-year-old man who was diagnosed with multiple lung metastases of sigmoid colon cancer. The patient developed progressive disease after 8 courses of bevacizumab + capecitabine and oxaliplatin therapy, therefore, bevacizumab + irinotecan, leucovorin, and 5-fluorouracil therapy was started. During the fifth course, he experienced pain on the left side of his chest. On computed tomography, bleeding from the pulmonary metastatic lesions was suspected. Two days later, a pneumothorax was detected. Although several cases of pneumothorax induced by bevacizumab have been reported, this case is the first documentation that bevacizumab caused a rupture of the lung metastatic lesion, leading to a pneumothorax.

Cite

CITATION STYLE

APA

Iida, T., Yabana, T., Nakagaki, S., Adachi, T., & Kondo, Y. (2016). A rupture of a lung metastatic lesion of colon cancer, leading to pneumothorax caused by bevacizumab. Internal Medicine, 55(21), 3125–3129. https://doi.org/10.2169/internalmedicine.55.7155

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free